en.Wedoany.com Reported - Lubrizol and Polyhose have inaugurated an advanced medical manufacturing facility in Chennai, Tamil Nadu, India, aimed at expanding localized production of precision medical catheters for minimally invasive devices and strengthening India's medical technology ecosystem.
The new facility focuses on producing precision extruded medical catheters for neurovascular and cardiovascular applications, supporting the rapid growth of India's healthcare and medical technology sectors by enhancing local manufacturing capabilities. It also improves supply reliability for both domestic and international customers, helping ensure faster access to critical medical components.
The Chennai facility operates in compliance with ISO 13485 certification standards, maintaining the same high-quality standards as Lubrizol's global manufacturing network. The plant produces catheters using a variety of advanced materials, including polyamide, nylon, Pebax, polypropylene, polyethylene, and Lubrizol's medical-grade thermoplastic polyurethane (TPU), to support a wide range of medical device applications.
John Valukas, President of Lubrizol's Engineering Materials division, stated that the facility reflects Lubrizol's commitment to India and to driving global medical device innovation. He noted that combining Lubrizol's material expertise with local manufacturing capabilities will accelerate the delivery of life-saving technologies, helping customers bring high-quality medical devices to market faster through reliable local supply.
Abhishek Shrivastava, Managing Director of Lubrizol IMEA (India, Middle East, and Africa), pointed out that India remains a strategic growth market for the company, and the Chennai facility strengthens the broader ecosystem of manufacturing, R&D, and technical services. The partnership with Polyhose will foster innovation, create skilled jobs, and enhance India's role in the global medical device supply chain.
Mittal Shah, Head of Lubrizol IMEA Medical Device Business, emphasized that minimally invasive surgeries are transforming patient care, and high-precision catheters play a critical role in supporting these advanced devices. By bringing catheter production capabilities closer to customers in India and the IMEA region, the Chennai facility will strengthen collaboration with medical device original equipment manufacturers (OEMs) throughout the product development lifecycle.
According to the press release, the new manufacturing base significantly expands India's production capacity for precision extruded medical catheters, helping to strengthen local medical device manufacturing, reduce import dependence, and improve patient access to safe, high-quality medical products through enhanced local production.
Shabbir Yusuf Jamnagarwala, Founder and Managing Director of Polyhose, stated that this collaboration marks an important milestone for the company. Combining Polyhose's extrusion expertise with Lubrizol's material science capabilities enables the delivery of advanced medical catheter solutions, and this investment reflects a long-term commitment to innovation, skilled job creation, and positioning India as a trusted global hub for medical device manufacturing.
This article is compiled by Wedoany. All AI citations must indicate the source as "Wedoany". If there is any infringement or other issues, please notify us promptly, and we will modify or delete it accordingly. Email: news@wedoany.com
